The cannabis company is tapping a veteran in biotechnology, investment banking and venture capital
Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) said Friday that it has named Frank Holler, a biotechnology, investment banking and venture capital industry veteran, as its chairman
The Vancouver-based company said in the press release that former Chairman Peter Wall will remain on the board.
READ: Harvest One Cannabis posts record revenue, enjoying boost from Dream Water subsidiary
Holler is president and CEO of Vancouver-based Ponderosa Capital Inc and previously held CEO roles at Lions Capital Corp, Xenon Pharmaceuticals Inc and ID Biomedical Corp. He was a founding director of Angiotech Pharmaceuticals, a Toronto Stock Exchange- and Nasdaq-listed medical device company that was sold in 2017.
Before working in biotechnology and health care, Holler was an investment banker at Merrill Lynch Canada.
"Frank's experience, particularly in the pharmaceutical industry and capital markets, strengthens the depth of expertise on the Harvest One board,” Harvest One CEO Grant Froese said.
Shares of Harvest One climbed C$0.01 to C$0.42 in Friday’s Canadian trading. They fetched US$0.32 on the OTC Markets.
Last month, the company posted record quarterly revenue driven by its Dream Water product line, acquired in May.
Contact Dennis Fitzgerald at [email protected]
